Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-05-14Clinical Trial Update: Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating fingolimod with fish oil in relapsing-remitting multiple sclerosis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Effects of Dalfampridine on Cognition in Multiple Sclerosis [Phase 2, Phase 3]
Clinical trial update on dalfampridine assessing cognitive effects in multiple sclerosis across Phase 2 and Phase 3, with completed status a…
-
CLINICAL_TRIALS research · 2019-04-30Clinical Trial Update: Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging [NA]
Clinical trial update on measuring cerebral blood flow with pseudo-continuous arterial spin labeling perfusion MRI; study status completed w…
-
FDA approval · 2019-04-24FDA Approved: TERIFLUNOMIDE — Original Application (MSN LABORATORIES PRIVATE LIMITED)
FDA approved the original application for a generic teriflunomide from MSN Laboratories Private Limited, indicated for relapsing forms of mu…
-
FDA approval · 2019-04-23FDA Approved: CAMPATH — Supplemental Application (Genzyme Corporation)
FDA approved a supplemental application for CAMPATH (alemtuzumab) submitted by Genzyme Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-19FDA Approved: TERIFLUNOMIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves the original application for Teriflunomide, a generic version manufactured by Alembic Pharmaceuticals Inc.
-
EMA safety_alert · 2019-04-12Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
EMA restricts the use of Lemtrada (alemtuzumab) while ongoing review is concluded, limiting certain patient groups and requiring adherence t…
-
FDA approval · 2019-03-29FDA Approved: MAVENCLAD — Original Application (EMD Serono, Inc.)
The FDA approved MAVENCLAD (cladribine) under its original application for the treatment of multiple sclerosis.
-
FDA approval · 2019-03-27FDA Approved: TIZANIDNE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved Tizanidine Hydrochloride as an original generic drug application for the management of spasticity in adults with multiple scler…
-
FDA approval · 2019-03-26FDA Approved: MAYZENT — Original Application (Novartis Pharmaceuticals Corporation)
FDA approves Mayzent (siponimod) from Novartis Pharmaceuticals Corporation in an original NDA for the treatment of relapsing forms of multip…
-
FDA approval · 2019-03-26FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original ANDA for tizanidine hydrochloride from Nivagen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 trial evaluating laquinimod for relapsing-remitting multiple sclerosis completed with results posted.
-
FDA approval · 2019-03-12FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for a generic tizanidine hydrochloride product.
-
FDA approval · 2019-03-11FDA Approved: DALFAMPRIDINE — Original Application (Micro Labs Limited)
FDA approved dalfampridine under an Original Application for Micro Labs Limited. The drug is intended to improve walking in adults with mult…
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients [Phase 4]
A Phase 4 clinical trial evaluated prolonged-release fampridine as an adjunct to active motor training in patients with multiple sclerosis.
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study [NA]
A completed feasibility trial sponsored by Hoffmann-La Roche evaluating the use of digital technology (smartphones and smartwatches) to moni…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis? [NA]
A completed clinical trial evaluating whether strength training and balance training improve gait function and fatigue in people with multip…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Upper Extremity Function, Shoulder Position Sense and Disability Level İn Patients With Multiple Sclerosis [NA]
A completed clinical trial from Ankara Yildirim Beyazıt University studied upper extremity function, shoulder position sense, and disability…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
A completed clinical trial evaluating fampridine's impact on cognition, fatigue, depression, and quality of life in individuals with multipl…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments
This clinical trial update reports on the Turkish version of the Mini-BESTest and assesses its validity and reliability in adults with senso…
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: Emotional Processing, Family Life, Friendship and Social Integration in Patients With Multiple Sclerosis [NA]
Clinical trial in multiple sclerosis examining emotional processing, family life, friendship, and social integration has completed. The upda…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Study to Evaluate the Reliability and Validity of the Modified Manual Muscle Test for Persons With MS [NA]
A completed study evaluating the reliability and validity of the Modified Manual Muscle Test in persons with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: LEAP a New Overground Body Weight Support Robot: Usability Trial [NA]
Completed usability trial of the LEAP overground body weight support robot evaluating its usability across conditions including spinal cord …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Cognitive Functions in Patients With Multiple Sclerosis
This clinical trial study completed its evaluation of cognitive functions in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: The Effect of Task-Oriented Training in Patients With Multiple Sclerosis [NA]
A completed clinical trial assessing the effectiveness of task-oriented training in patients with multiple sclerosis, sponsored by Gazi Univ…